Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures

Journal of Gastroenterology

Volumn 40, Issue 7, 2005, Pages 698-707

  Komatsu, Tomoko ^a   Tamai, Yoshiko ^a   Takami, Hideki ^b   Yamagata, Kazufumi ^a   Fukuda, Shinsaku ^a   Munakata, Akihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Anti platelet agents; Cessation period; Invasive endoscopic procedure; Quantitative bleeding time test

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD SAMPLING; DRUG CLEARANCE; DRUG DOSE REGIMEN; GASTROINTESTINAL ENDOSCOPY; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; TIME; TIME SERIES ANALYSIS;

ADULT; ASPIRIN; BLEEDING TIME; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MAXIMUM TOLERATED DOSE; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TICLOPIDINE; TIME FACTORS;

EID: 25144520250     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-005-1613-0     Document Type: Article

References (44)

1. Antiplatelet Trialists' Collaboration 1988 Secondary prevention of vascular disease by prolonged antiplatelet treatment BMJ 296 320-31
2. Antiplatelet Trialists' Collaboration 1994 Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 81-106
3. Antiplatelet Trialists' Collaboration 2002 Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 71-86
4. American Society for Gastrointestinal Endoscopy 1998 Guidelines on the management of anticoagulation and antiplatelet therapy for endoscopic procedures Gastrointest Endosc 48 672-5
5. AM Miller D McGill ML Bassett 1999 Anticoagulant therapy, anti-platelet agents and gastrointestinal endoscopy J Gastroenterol Hepatol 14 109-13 10.1046/j.1440-1746.1999.01816.x 10029289
6. GM Eisen TH Baron JA Dominitz DO Faigel JL Goldstein JF Johanson et al. 2002 Guidelines on the management of anticoagulation and antiplatelet therapy for endoscopic procedures Gastrointest Endosc 55 775-9 10.1067/ mge.2002.123619 12024126
7. A Hittelet J Deviere 2003 Management of anticoagulants before and after endoscopy Can J Gastroenterol 17 329-32 12772008
8. AJ Hui RM Wong JY Ching LC Hung SC Chung JJ Sung 2004 Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: Analysis of 1657 cases Gastrointest Endosc 59 44-8 10.1016/ S0016-5107(03)02307-1 14722546
9. LA Harker CA Finch 1969 Thrombokinetics in man J Clin Invest 48 963-74 5814231
10. M Baldini N Costea W Dameshek 1960 The viability of stored human platelets Blood 16 1669-92 13686272
11. GR Buchanan V Martin PH Levine K Scoon RI Handin 1977 The effect of "anti-platelet" drugs on bleeding time and platelet aggregation in normal human subjects Am J Clin Pathol 68 355-9 331937
12. EM Pogliani C Fowst R Bregani G Corneo 1992 Bleeding time and antiplatelet agents in normal volunteers Int J Clin Lab Res 22 58-61 1633323
13. H Nakajima H Takami K Yamagata K Kariya Y Tamai H Nara 1997 Aspirin effects on colonic mucosal bleeding: Implications for colonic biopsy and polypectomy Dis Colon Rectum 40 1484-8 9407989
14. JR Sonksen KL Kong R Holder 1999 Magnitude and time course of impaired primary haemostasis after stopping chronic low and medium dose aspirin in healthy volunteers Br J Anaesth 82 360-5 10434816
15. NM Gibbs WM Weightman NM Thackray N Michalopoulos C Weidmann 2001 The effects of recent aspirin ingestion on platelet function in cardiac surgical patients J Cardiothorac Vasc Anesth 15 55-9 10.1053/ jcan.2001.20277 11254841
16. Y Tamai H Takami R Nakahata Y Nakui T Akagi A Munakata 1998 Development and practical use of the new quantitative bleeding time test apparatus Thromb Haemost 80 181-5 9684807
17. Y Tamai H Takami A Munakata 1999 Primary hemostasis and bleeding time test Hirosaki Med J 51 S10-S5
18. Y Tamai H Takami R Nakahata F Ono A Munakata 1999 Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemosatasis using a quantitative bleeding time test apparatus Haemostasis 29 269-76 10.1159/000022512 10754379
19. Y Tamai H Takami R Nakahata A Munakata 1999 Good correlation between clinical bleeding tendencies and bleeding pattern from the bleeding time incision Thromb Res 95 131-4 10.1016/S0049-3848(99)00025-0 10418802
20. Y Ozaki K Satoh T Yamamoto Y Shirasawa S Kume 1994 Detection of platelet aggregates with a particle counting method using light scattering Anal Biochem 218 284-94 10.1006/abio.1994.1180 8074282
21. CAST (Chinese Acute Stroke Trial) Collaborative Group 1997 CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke Lancet 349 1641-9
22. International Stroke Trial Collaborative Group 1997 The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 35 patients with acute ischaemic stroke Lancet 349 1569-81
23. PA Wolf GP Clagett JD Easton LB Goldstein PB Gorelick M Kelly-Hayes et al. 1999 Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: A statement for healthcare professionals from the Stroke Council of the American Heart Association Stroke 30 1991-4 10471455
24. GJ Hankey CL Sudlow DW Dunbabin 2000 Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials Stroke 31 1779-84 10884487
25. S Yusuf F Zhao SR Mehta S Chrolavicius G Tognoni KK Fox 2001 Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494-502 10.1056/NEJMoa010746 11519503
26. RA Harrington PK Hodgson RL Larsen 2003 Cardiology patient page. Antiplatelet therapy Circulation 108 e45-7 10.1161/ 01.CIR.0000083142.13956.D6 12925447
27. RA Lange LD Hillis 2004 Antiplatelet therapy for ischemic heart disease N Engl J Med 350 277-80 10.1056/NEJMe038191 14724308
28. L Janzon D Bergqvist J Boberg M Boberg I Eriksson F Lindgarde et al. 1990 Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study J Intern Med 227 301-8 2187948
29. JJ Popma EM Ohman J Weitz AM Lincoff RD Harrington P Berger 2001 Antithrombotic therapy in patients undergoing percutaneous coronary intervention Chest 119 321S-36S 10.1378/chest.119.1≻ppl.321S 11157657
30. WK Hass JD Easton HP Jr Adams W Pryse-Phillips BA Molony A Anderson et al. 1989 A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group N Engl J Med 321 501-7 2761587
31. MB Leon DS Baim JJ Popma PC Gordon DE Cutlip KK Ho et al. 1998 A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1665-71 10.1056/NEJM199812033392303 9834303
32. CM Goods KF al-Shaibi MW Liu JS Yadav A Mathur SP Jain et al. 1996 Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting Am J Cardiol 78 1042-4 10.1016/ S0002-9149(96)00532-2 8916486
33. ML Shiffman MT Farrel YS Yee 1994 Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS Gastrointest Endosc 40 458-62 7926536
34. ML Freeman DB Nelson S Sherman GB Haber ME Herman PJ Dorsher et al. 1996 Complications of endoscopic biliary sphincterotomy N Engl J Med 335 909-18 10.1056/NEJM199609263351301 8782497
35. SC Kadakia CE Angueira JA Ward M Moore 1996 Gatrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: Survey of ASGE members. American Society for Gatrointestinal Endoscopy Gastrointest Endosc 44 309-16 8885352
36. C Patrono 1994 Aspirin as an antiplatelet drug N Engl J Med 330 1287-94 10.1056/NEJM199405053301808 8145785
37. SI Ashida Y Abiko 1979 Inhibition of platelet aggregation by a new agent, ticlopidine Thromb Haemost 40 542-50 425067
38. LD Fiore MT Brophy A Lopez P Janson D Deykin 1990 The bleeding time response to aspirin. Identifying the hyperresponder Am J Clin Pathol 94 292-6 2396603 2396603
39. JM Herbert A Bernat M Samama JP Maffrand 1996 The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat Thromb Haemost 76 94-8 8819259
40. AI Schafer 1996 Antiplatelet therapy Am J Med 101 199-209 10.1016/ S0002-9343(96)80077-5 8757361
41. H Tohgi H Takahashi K Watanabe H Kuki Y Shirasawa 1996 Development of large platelet aggregates from small aggregates as determined by laser-light scattering: Effects of aggregant concentration and antiplatelet medication Thromb Haemost 75 838-43 8725733
42. K Eto S Takeshita M Ochiai Y Ozaki T Sato T Isshiki 1998 Platelet aggregation in acute coronary syndromes: Use of a new aggregometer with laser light scattering to assess platelet aggregability Cardiovasc Res 40 223-9 10.1016/S0008-6363(98)00114-X 9876335
43. JC O'Laughlin JW Hoftiezer JP Mahoney KJ Ivey 1981 Does aspirin prolong bleeding from gastric biopsies in man? Gastrointest Endosc 27 1-5 6971236
44. MD Basson L Panzini RH Palmer 2001 Effect of nabumetone and aspirin on colonic mucosal bleeding time Aliment Pharmacol Ther 15 539-42 10.1046/ j.1365-2036.2001.00948.x 11284783